Artificial intelligence (AI) is rapidly transforming heart failure (HF) management, offering advances from early risk prediction to treatment and continuous monitoring. A recent review led by Professor Yi-Da Tang highlights how AI integrates electronic health records, multimodal imaging, and wearable technologies to enable personalized HF care. While challenges in generalizability, interpretability, and reliability remain, ongoing innovation and validation efforts are expected to accelerate clinical translation and improve outcomes for HF patients.

Sox9, a master regulator of cartilage formation, switches its target genes dynamically during embryonic limb development instead of following a fixed program, as reported by researchers from Science Tokyo. They analyzed mouse embryonic forelimb cells across different developmental stages using single-cell-level gene expression analysis and a state-of-the-art technique to detect Sox9’s DNA binding sites. The findings lay the foundation for future research on skeletal diseases and regenerative medicine.

A team from the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and Hospital Puerta de Hierro in Madrid, working together with investigators at Hospital Germans Trias i Pujol in Barcelona, has identified a biomarker that could improve risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive and potentially fatal disease.

Integrating mechanobiological principles into disease pathogenesis, therapeutic development, and tissue engineering is reshaping our understanding of biological systems and accelerating the advancement of mechanotherapy and mechanohealth. This field reveals how mechanical cues regulate cellular behavior, such as force transmission along integrin-nucleus pathways and collective cell migration, and tissue functions. In doing so, mechanobiology connects fundamental research with clinical applications, from limiting cancer metastasis and fibrosis to promoting bone regeneration and maintaining vascular homeostasis. Building on discussion from the Inaugural International Conference on Mechanobiology (ICM) 2025, integrating mechanobiological research with clinical strategies offers new opportunities to address unmet needs, including personalized anti-fibrotic interventions or precision bone regenerative therapies. At the same time, it supports the broader concept of mechanohealth -- a paradigm focused on preserving the physiological mechanical balance within tissues.

A new study published in Earth’s Future introduces the eLTER Framework of Standard Observations (eLTER SO) - a structured, harmonized system designed to support consistent long-term environmental observation across Europe. The paper, "Achieving harmonized and integrated long-term environmental observation of essential ecosystem variables - The eLTER Framework of Standard Observations", explains how the eLTER Research Infrastructure (eLTER RI) is improving the comparability and coordination of environmental data across diverse ecosystems and research fields. By providing common standards, the framework improves data interoperability and supports collaboration across the environmental research community. It offers a foundation for future work in areas such as ecosystem modeling, sustainability assessments, and evidence-based environmental policy.

Researchers have developed a microscale organic-inorganic hybridization strategy integrating biosafety, physiological compatibility, biomechanics, and biocatalysis. Guided by natural biomacromolecules, these hybrid units behave like flexible polymer chains rather than rigid nanoparticles. The resulting hydrogel enhances mammalian cell synthesis of high-value therapeutic proteins by nearly tenfold. Crucially, it ameliorates hypoxia and boosts mitochondrial respiration without external oxygen supply, demonstrating immense potential in 3D bioprinting and hydrogel-derived optical fibers.

Tiny etched structures sit at the heart of many modern sensors and microsystems, but judging whether those structures were made correctly still depends heavily on slow human inspection. 

SlMYB32 was identified as a repressor regulating phenylpropanoid pathway. CRISPR/Cas9-mediated mutagenesis of SlMYB32 results in flavonol-rich tomatoes with 1 mg g^-1 FW rutin.

Researchers have developed a cobalt dual-atom catalyst with dioxygen-bridged cobalt sites embedded in hierarchically porous carbon nanospheres. This catalyst significantly enhances the oxygen reduction reaction efficiency by breaking traditional adsorption scaling relationships. It outperforms commercial platinum catalysts and enables high-performance zinc-air batteries capable of long-term operation and powering electronic devices.